- ISIN
- US45688C1071
- CUSIP
- 45688C107
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- IPO Date
- May 2, 2016
Highlights
- Market Cap
- $2.54B
- Enterprise Value
- $4.85B
- EPS (TTM)
- $1.50
- PE Ratio
- 48.84
- PEG Ratio
- 3.10
- Total Revenue (TTM)
- $1.16B
- Gross Profit (TTM)
- $477.10M
- EBITDA (TTM)
- $150.80M
- Year Range
- $40.40 - $79.29
- Target Price
- $82.50
- ROA (TTM)
- 3.51%
- ROE (TTM)
- 115.14%
- Avg. Volume (1M)
- 236K
- Avg. Volume Value (1M)
- $17.22M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
NGVT Performance Chart
Ingevity Corporation (NGVT) is up 23.5% since the beginning of the year. At $73 per share, NGVT is trading 7.8% below its 52-week high of $79. Investors who bought $1,000 worth of NGVT shares 5 years ago would now be looking at an investment worth $861.
Loading charts...
Compare this symbol against anything
Returns By Period
Ingevity Corporation (NGVT) has returned 23.54% so far this year and 80.97% over the past 12 months. Over the last ten years, NGVT has returned 6.89% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Ingevity Corporation
- 1D
- 4.16%
- 1M
- 0.86%
- 6M
- 11.13%
- YTD
- 23.54%
- 1Y
- 80.97%
- 3Y*
- 5.44%
- 5Y*
- -2.96%
- 10Y*
- 6.89%
- ALL TIME*
- 12.44%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
NGVT Monthly Returns History
Based on dividend-adjusted daily data since May 2, 2016, NGVT's average daily return is +0.08%, while the average monthly return is +1.86%. At this rate, an investment would double in approximately 3.1 years.
Historically, 55% of months were positive and 45% were negative. The best month was Apr 2020 with a return of +47.5%, while the worst month was May 2023 at -34.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.
On a daily basis, NGVT closed higher 50% of trading days. The best single day was Aug 5, 2025 with a return of +21.3%, while the worst single day was Mar 9, 2020 at -19.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.17% | 9.48% | -1.11% | 6.96% | -10.99% | 10.10% | -2.09% | 23.54% | |||||
| 2025 | 11.29% | 5.09% | -16.93% | -16.70% | 25.44% | 4.16% | -3.02% | 39.70% | -5.46% | -2.66% | -2.77% | 13.31% | 45.23% |
| 2024 | -7.75% | 4.87% | 4.42% | 7.21% | -4.48% | -10.52% | 4.99% | -13.86% | -1.34% | 7.15% | 16.22% | -16.10% | -13.70% |
| 2023 | 17.04% | 0.15% | -13.37% | 0.31% | -34.22% | 23.25% | 10.08% | -15.82% | -11.65% | -15.40% | -3.70% | 21.73% | -32.96% |
| 2022 | -8.08% | 3.52% | -6.10% | -6.51% | 16.33% | -9.39% | 6.27% | 4.53% | -13.56% | 10.95% | 16.35% | -10.00% | -1.76% |
| 2021 | -13.26% | 5.77% | 8.71% | 3.38% | 5.42% | -1.15% | 4.40% | -5.36% | -11.22% | 9.16% | -7.70% | -0.29% | -5.32% |
Benchmark Metrics
Ingevity Corporation has an annualized alpha of 3.25%, beta of 1.28, and R2 of 0.27 versus S&P 500 Index. Calculated based on daily prices since May 02, 2016.
- This stock captured 157.32% of S&P 500 Index gains and 155.81% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.27 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 3.25%
- Beta
- 1.28
- R²
- 0.27
- Upside Capture
- 157.32%
- Downside Capture
- 155.81%
Return for Risk
Risk / Return Rank
NGVT ranks 88 for risk / return — above 88% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Ingevity Corporation (NGVT) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NGVT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.36 | ||
| Sortino ratioReturn per unit of downside risk | +0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.25 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 3.15 | 2.00 | +1.14 |
| Martin ratioReturn relative to average drawdown | 8.53 | 8.49 | +0.03 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Ingevity Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ingevity Corporation was 76.22%, occurring on Mar 18, 2020. The portfolio has not yet recovered.
The current Ingevity Corporation drawdown is 37.55%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-76.22%Mar 2020 | 1y 26d | — | 7y 5moFeb 2019 - now | COVID crash2020 |
-28.04%Dec 2018 | 3mo 1d | 1mo 22d | 4mo 23dSep 2018 - Feb 2019 | Rate-hike selloffLate 2018 |
-17.20%Jun 2017 | 2mo | 3mo 7d | 5mo 7dApr 2017 - Oct 2017 | — |
-14.95%Nov 2016 | 1mo 7d | 9d | 1mo 16dSep 2016 - Nov 2016 | — |
-13.13%Feb 2018 | 2mo 9d | 15d | 2mo 24dDec 2017 - Feb 2018 | — |
Drawdown Indicators
| NGVT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.22% | -56.78% | -19.44% |
Max Drawdown (1Y)Largest decline over 1 year | -23.94% | -9.10% | -14.84% |
Max Drawdown (3Y)Largest decline over 3 years | -48.62% | -18.90% | -29.72% |
Max Drawdown (5Y)Largest decline over 5 years | -67.07% | -25.43% | -41.64% |
Max Drawdown (10Y)Largest decline over 10 years | -76.22% | -33.92% | -42.30% |
Current DrawdownCurrent decline from peak | -37.55% | -1.58% | -35.97% |
Average DrawdownAverage peak-to-trough decline | -34.66% | -10.70% | -23.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.82% | 2.14% | +6.68% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Ingevity Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Ingevity Corporation is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for NGVT, comparing it with other companies in the Specialty Chemicals industry. Currently, NGVT has a P/E ratio of 48.8. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for NGVT compared to other companies in the Specialty Chemicals industry. NGVT currently has a PEG ratio of 3.1. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for NGVT relative to other companies in the Specialty Chemicals industry. Currently, NGVT has a P/S ratio of 2.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for NGVT in comparison with other companies in the Specialty Chemicals industry. Currently, NGVT has a P/B value of 55.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with NGVT
Add Ingevity Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with NGVT